Villaris Therapeutics

A preclinical-stage biopharmaceutical company.

HQ location

Cary, United States

Website

Launch date

2018

Date	Investors	Amount	Round
Oct 2022*	Incyte	$70.0m	Acquisition
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads